Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
Tohid MortezazadehElham GholibeglooNader Riyahi AlamSadegh DehghaniSoheila HaghgooHossein GhanaatiMehdi KhoobiPublished in: Magma (New York, N.Y.) (2019)
The results indicate the potential of Gd2O3@PCD-FA to serve as a novel targeted nano-contrast agent in MRI.
Keyphrases
- contrast enhanced
- oxide nanoparticles
- magnetic resonance
- magnetic resonance imaging
- cancer therapy
- papillary thyroid
- ionic liquid
- computed tomography
- diffusion weighted imaging
- squamous cell
- drug delivery
- squamous cell carcinoma
- drug release
- case control
- climate change
- mass spectrometry
- molecularly imprinted
- risk assessment
- solid phase extraction